Application 202007

Type
NDA
Sponsor
CIPLA LIMITED

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ABACAVIR SULFATE; LAMIVUDINEABACAVIR SULFATE; LAMIVUDINETABLET, FOR SUSPENSION; ORAL60MG; 30MGNoNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
9940ORIG2011-05-16